Search

everythinglearnresearchcommunity

for

Search:↓

Particulate matter causes inflammation in hair cells, potentially harming hair growth.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Fzd2 is important for skin and hair development through various signaling ways.

Current treatments for non-scarring alopecia have limited effectiveness and side effects, while natural remedies may offer safer alternatives but need more research.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Oral Janus kinase inhibitors may be an effective treatment option for lichen planopilaris with some risk of increased cholesterol and liver enzyme levels.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Melatonin affects specific gene patterns and biological processes in goat hair growth.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Alopecia areata affects women and young adults most, with low SDI regions seeing the highest increase, and new treatments like JAK inhibitors are being explored.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.